JILIN AODONG PHARMACEUTICAL GROUP CO., LTD.

Andere talen Jilin Aodong Pharmaceutical Group Co., Ltd.

Aandelen

000623

CNE000000719

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 16-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
14,83 ^CNY	-0,13%		-1,59%	-2,05%

29/04	Jilin Aodong Pharmaceutical Group Co, Ltd. Rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
17/04	Aodong Medicine's 2023 winst daalt met 18%; omzet stijgt met 20%	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20%	17/04
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	16/04
Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.	17/11
Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback announced on September 21, 2023, has closed with 9,015,780 shares, representing 0.8% for CNY 150 million.	17/11
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30-10-23
Chinese listed firms used endangered animal parts as ingredients -report	23-10-23
Three listed Chinese firms used endangered animal parts as ingredients- report	23-10-23
Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.	09-10-23
Jilin Aodong Pharmaceutical Group Co., Ltd. announces an Equity Buyback for CNY 150 million worth of its shares.	20-09-23
Jilin Aodong Pharmaceutical Group Co., Ltd. authorizes a Buyback Plan.	20-09-23
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. cancelled the acquisition of Beijing Langyan Life Technology Holdings Co., Ltd. from a group of shareholders.	04-09-23
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	30-08-23
Jilin Aodong Yanbian Pharmaceutical Co., Ltd. announced that it expects to receive CNY 200 million in funding from Jilin Aodong Pharmaceutical Group Co., Ltd.	30-08-23
Jilin Aodong Pharmaceutical Group Co., Ltd. Elects Liang Biming as Independent Director	18-07-23
Aodong Medicine's Unit Gets Registration Certificate for 16 Formula Tablets	05-07-23
Jilin Aodong Pharmaceutical Group Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on July 7, 2023	29-06-23
Jilin Aodong Pharmaceutical Group Co., Ltd Approves the Profit Distribution Proposal for 2022	16-05-23
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28-04-23
Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback announced on May 6, 2022, has expired.	28-04-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Jilin Aodong Pharmaceutical Group Co., Ltd.

Aandelen

000623

CNE000000719

Andere talen

Filters